Cargando…
New solutions for old challenges in glaucoma treatment: is taurine an option to consider?
Glaucoma is a range of progressive optic neuropathies characterized by progressive retinal ganglion cell loss and visual field defects. It is recognized as a leading cause of irreversible blindness affecting more than 70 million people worldwide. Currently, reduction of intraocular pressure, a widel...
Autores principales: | Iezhitsa, Igor, Agarwal, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178787/ https://www.ncbi.nlm.nih.gov/pubmed/33229737 http://dx.doi.org/10.4103/1673-5374.297059 |
Ejemplares similares
-
Magnesium acethyltaurate as a potential agent for retinal and optic nerve protection in glaucoma
por: Iezhitsa, Igor, et al.
Publicado: (2018) -
Taurine protects against retinal and optic nerve damage induced by endothelin-1 in rats via antioxidant effects
por: Nor Arfuzir, Natasha Najwa, et al.
Publicado: (2018) -
Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
por: Jafri, Azliana Jusnida Ahmad, et al.
Publicado: (2018) -
Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
por: Lambuk, Lidawani, et al.
Publicado: (2022) -
Management of exfoliative glaucoma: challenges and solutions
por: Holló, Gábor, et al.
Publicado: (2015)